Key statistics
On Thursday, ProQR Therapeutics NV (PRQRN:MEX) closed at 36.00, 0.00% below its 52-week high of 36.00, set on Sep 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 36.00 |
---|---|
High | 36.00 |
Low | 36.00 |
Bid | -- |
Offer | 40.00 |
Previous close | 36.00 |
Average volume | -- |
---|---|
Shares outstanding | 81.68m |
Free float | 66.33m |
P/E (TTM) | -- |
Market cap | 152.74m USD |
EPS (TTM) | -0.2908 USD |
Data delayed at least 20 minutes, as of Sep 12 2024 14:04 BST.
More ▼
Announcements
- ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society
- ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference
- ProQR Announces Second Quarter 2024 Operating and Financial Results
- ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit
- ProQR Announces First Quarter 2024 Operating and Financial Results
- ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases
- ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
- ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
- ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
- ProQR Announces Year End 2023 Operating and Financial Results
More ▼